Platelet-activating Factor Increases Endothelial [Ca2+]i and NO Production in Individually Perfused Intact Microvessels
Overview
Physiology
Authors
Affiliations
We have demonstrated that inhibition of NO synthase (NOS) in endothelial cells by either the NOS inhibitor N(omega)-monomethyl-l-arginine (l-NMMA) or the internalization of caveolin-1 scaffolding domain attenuated platelet-activating factor (PAF)-induced increases in microvessel permeability (Am J Physiol Heart Circ Physiol 286: H195-H201, 2004) indicating the involvement of an NO-dependent signaling pathway. To investigate whether an increase in endothelial cytoplasmic Ca(2+) concentration ([Ca(2+)](i)) is the initiating event and Ca(2+)-dependent NO production is crucial for permeability increases, PAF (10 nM)-induced changes in endothelial [Ca(2+)](i) and NO production were measured in individually perfused rat mesenteric venular microvessels via fluorescence microscopy. When venular microvessels were exposed to PAF, endothelial [Ca(2+)](i) increased from 69 +/- 8 nM to a peak value of 374 +/- 26 nM within 3 min and then declined to a sustained level at 190 +/- 12 nM after 15 min. Inhibition of NOS did not modify PAF-induced increases in endothelial [Ca(2+)](i). PAF-induced NO production was visualized and quantified at cellular levels in individually perfused microvessels using 4,5-diaminofluorescein diacetate and fluorescence imaging. Increased fluorescence intensity (FI), which is an indication of increased NO production, occurred in 75 +/- 7% of endothelial cells in each vessel. The mean maximum FI increase was 140 +/- 7% of baseline value. This increased FI was abolished by pretreatment of the vessel with l-NMMA and attenuated in the absence of extracellular Ca(2+). These results provide direct evidence from intact microvessels that increased endothelial [Ca(2+)](i) is the initial signal that activates endothelial NOS, and the subsequent increased NO production contributes to PAF-induced increases in microvessel permeability.
Endothelial mechanobiology in atherosclerosis.
Wang X, Shen Y, Shang M, Liu X, Munn L Cardiovasc Res. 2023; 119(8):1656-1675.
PMID: 37163659 PMC: 10325702. DOI: 10.1093/cvr/cvad076.
Gao F, Sun H, Li X, He P Am J Physiol Heart Circ Physiol. 2021; 322(1):H71-H86.
PMID: 34767485 PMC: 8698539. DOI: 10.1152/ajpheart.00478.2021.
Oxidative Stress and Microvessel Barrier Dysfunction.
He P, Talukder M, Gao F Front Physiol. 2020; 11:472.
PMID: 32536875 PMC: 7268512. DOI: 10.3389/fphys.2020.00472.
Zhou X, Qian Y, Yuan D, Feng Q, He P Physiol Rep. 2019; 7(16).
PMID: 31448579 PMC: 6709418. DOI: 10.14814/phy2.14206.
Feng Q, Stork C, Xu S, Yuan D, Xia X, LaPenna K J Physiol. 2018; 597(3):781-798.
PMID: 30548258 PMC: 6355626. DOI: 10.1113/JP277312.